Topics
Glioblastoma | Treatment | Theranostics
Home > Publications > Topics > Glioblastoma > Treatment > Theranostics
Biau J, Durando X, Boux F, Molnar I, Moreau J, Leyrat B, Guillemin
F, Lavielle A, Cremillieux Y, Seddik K, Dufort S, De Beaumont O,
Thivat E, Le Duc G.
NANO-GBM trial of
AGuIX nanoparticles with radiotherapy and temozolomide in the
treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and
MRI-based biodistribution.
Clin
Transl Radiat Oncol. 2024 Jul 31;48:100833. doi:
10.1016/j.ctro.2024.100833. PMID:
39184998. Interventional study. ˍ
Kumar A, Shukla R.
Current strategic
arsenal and advances in nose to brain nanotheranostics for
therapeutic intervention of glioblastoma multiforme.
J
Biomater Sci Polym Ed. 2024 Sep 9:1-35. doi:
10.1080/09205063.2024.2396721. PMID:
39250527. Review˰ ˍ
*Sangubotla R, Gubbiyappa KS, Devarapogu R, Kim J.
Modern
insights of nanotheranostics
in the glioblastoma: An updated review.
Biochim
Biophys Acta Mol
Basis Dis. 2025 Jan 3:167653. doi:
10.1016/j.bbadis.2024.167653. PMID:
39756713. Review˰
ˍ